A detailed history of Cohen Klingenstein LLC transactions in Haleon PLC stock. As of the latest transaction made, Cohen Klingenstein LLC holds 120,042 shares of HLN stock, worth $1.05 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
120,042
Previous 152,042 21.05%
Holding current value
$1.05 Million
Previous $1.25 Million 18.55%
% of portfolio
0.04%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$8.02 - $8.67 $256,640 - $277,440
-32,000 Reduced 21.05%
120,042 $1.02 Million
Q4 2023

Jan 12, 2024

SELL
$7.78 - $8.62 $127,981 - $141,799
-16,450 Reduced 9.76%
152,042 $1.25 Million
Q3 2023

Oct 13, 2023

SELL
$7.85 - $8.94 $12,905 - $14,697
-1,644 Reduced 0.97%
168,492 $1.4 Million
Q4 2022

Jan 13, 2023

SELL
$6.08 - $8.06 $251,493 - $333,393
-41,364 Reduced 19.56%
170,136 $0
Q3 2022

Oct 12, 2022

BUY
$5.63 - $7.49 $1.19 Million - $1.58 Million
211,500 New
211,500 $1.29 Million

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $40.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cohen Klingenstein LLC Portfolio

Follow Cohen Klingenstein LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cohen Klingenstein LLC with notifications on news.